Synthesis of thiazole linked chalcones and their pyrimidine analogues as anticancer agents

References

• Bray, F.; Ferlay, J.; Isabelle, S.; Rebecca, L. S.; Lindsey, A. T.; Ahmedin, J. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Fojo, T.; Parkinson, D. R. Biologically Targeted Cancer Therapy and Marginal Benefits: Are we Making Too Much of Too Little or Are we Achieving Too Little by Giving Too Much? Clin. Cancer Res. 2010, 16, 5972–5980. DOI: 10.1158/1078-0432.CCR-10-1277.
   PubMed Web of Science ®Google Scholar
• Glimelius, B.; Cavalli-Bjorkman, N. Metastatic Colorectal Cancer: Current Treatment and Future Options for Improved Survival. Medical Approach-Present Status. Scand. J. Gastroenterol. 2012, 47, 296–314. DOI: 10.3109/00365521.2012.640828.
   PubMed Web of Science ®Google Scholar
• Tournigand, C.; André, T.; Achille, E.; Lledo, G.; Flesh, M.; Mery-Mignard, D.; Quinaux, E.; Couteau, C.; Buyse, M.; Ganem, G.; et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study. J. Clin. Oncol. 2004, 22, 229–237. DOI: 10.1200/JCO.2004.05.113.
   PubMed Web of Science ®Google Scholar
• Tannaz, A.; Jon, D. W.; Quyen, C.; Glenn, M. Genetic Alterations in Colorectal Cancer. Gastrointest. Cancer Res. 2012, 5, 19–27.
   PubMedGoogle Scholar
• Mouradov, D.; Sloggett, C.; Jorissen, R. N.; Love, C. G.; Li, S.; Burgess, A. W.; Arango, D.; Strausberg, R. L.; Buchanan, D.; Wormald, S.; et al. Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer. Cancer Res. 2014, 74, 3238–3247. DOI: 10.1158/0008-5472.CAN-14-0013.
   PubMed Web of Science ®Google Scholar
• Syam, S.; Abdelwahab, S. I.; Al–Mamary, M. A.; Mohan, S. Synthesis of Chalcones with Anticancer Activities. Molecules. 2012, 17, 6179–6195. DOI: 10.3390/molecules17066179.
   PubMed Web of Science ®Google Scholar
• Nielsen, S. F.; Boesen, T.; Larsen, M.; Schønning, K.; Kromann, H. Antibacterial Chalcones-Bioisosteric Replacement of the 4′-hydroxy Group. Bioorg. Med. Chem. 2004, 12, 3047–3054. DOI: 10.1016/j.bmc.2004.03.071.
   PubMed Web of Science ®Google Scholar
• Lahtchev, K. L.; Batovska, D. I.; Parushev, S. P.; Ubiyvovk, V. M.; Sibirny, A. A. Antifungal Activity of Chalcones: A Mechanistic Study Using Various Yeast Strains. Eur. J. Med. Chem. 2008, 43, 2220–2228. DOI: 10.1016/j.ejmech.2007.12.027.
   PubMed Web of Science ®Google Scholar
• Hsieh, C. T.; Hsieh, T. J.; El–Shazly, M.; Chuang, D. W.; Tsai, Y. H.; Yen, C. T.; Wu, S. F.; Wu, Y. C.; Chang, F. R. Synthesis of Chalcone Derivatives as Potential anti-Diabetic Agents. Bioorg. Med. Chem. Lett. 2012, 22, 3912–3915. DOI: 10.1016/j.bmcl.2012.04.108.
   PubMed Web of Science ®Google Scholar
• Nowakowska, Z. A Review of anti-Infective and anti-Inflammatory Chalcones. Eur. J. Med. Chem. 2007, 42, 125–137. DOI: 10.1016/j.ejmech.2006.09.019.
   PubMed Web of Science ®Google Scholar
• Maioral, M. F.; Gaspar, P. C.; Rosa Souza, G. R.; Mascarello, A.; Chiaradia, L. D.; Licinio, M. A.; Moraes, A. C.; Yunes, R. A.; Nunes, R. J.; Santos-Silva, M. C. Apoptotic Events Induced by Synthetic Naphthylchalcones in Human Acute Leukemia Cell Lines. Biochimie. 2013, 95, 866–874. DOI: 10.1016/j.biochi.2012.12.001.
   PubMed Web of Science ®Google Scholar
• Jamier, V.; Marut, W.; Valente, S.; Chereau, C.; Chouzenoux, S.; Nicco, C.; Lemarechal, H.; Weill, B.; Kirsch, G.; Jacob, C.; Batteux, F. Chalcone-Coumarin Derivatives as Potential anti-Cancer Drugs: An in Vitro and in Vivo Investigation. Anticancer Agents Med. Chem. 2013, 14, 963–974. DOI: 10.2174/1871520613666131224124445.
   Web of Science ®Google Scholar
• Drutovic, D.; Chripkova, M.; Pilatova, M.; Kruzliak, P.; Perjesi, P.; Sarissky, M.; Lupi, M.; Damia, G.; Broggini, M.; Mojzis, J. Benzylidenetetralones, Cyclic Chalcone Analogues, Induce Cell Cycle Arrest and Apoptosis in HCT116 Colorectal Cancer Cells. Tumour Biol. 2014, 35, 9967–9975. DOI: 10.1007/s13277-014-2289-y.
   PubMedGoogle Scholar
• Mathew, B.; Suresh, J.; Anbazghagan, S.; Paulraj, J.; Krishnan, G. K. Heteroaryl Chalcones: Mini Review about Their Therapeutic Voyage. Biomed. Prev. Nutr. 2014, 4, 451–458. DOI: 10.1016/j.bionut.2014.04.003.
   Google Scholar
• Firoozpour, L.; Edraki, N.; Nakhjiri, M.; Emami, S.; Safavi, M.; Ardestani, S. K.; Khoshneviszadeh, M.; Shafiee, A.; Foroumadi, A. Cytotoxic Activity Evaluation and QSAR Study of Chromene-Based Chalcones. Arch. Pharm. Res. 2012, 35, 2117–2125. DOI: 10.1007/s12272-012-1208-2.
   PubMed Web of Science ®Google Scholar
• Noushini, S.; Alipour, E.; Emami, S.; Safavi, M.; KabudanianArdestani, S.; Gohari, A. R.; Shafiee, A.; Foroumadi, A. Synthesis and Cytotoxic Properties of Novel (E)-3-Benzylidene-7-Methoxychroman-4-One Derivatives. DARUJ. Pharm. Sci. 2013, 21, 31. DOI: 10.1186/2008-2231-21-31.
   Web of Science ®Google Scholar
• Letafat, B.; Shakeri, R.; Emami, S.; Noushini, S.; Mohammadhosseini, N.; Shirkavand, N.; Kabudanian Ardestani, S.; Safavi, M.; Samadizadeh, M.; Letafat, A.; et al. Synthesis and in Vitro Cytotoxic Activity of Novel Chalcone-like Agents. Iran. J. Basic Med. Sci. 2013, 16, 1155–1162.
   PubMed Web of Science ®Google Scholar
• Ankita, K.; Nayana, A.; Arpita, D.; Anshul, S.; Surajit, K. G.; Udaya, P. S.; Hans, R. B. Review on Synthetic Chemistry and Antibacterial Importance of Thiazole Derivatives. Curr. Drug Discov. Technol. 2018, 15, 214–228. DOI: 10.2174/1570163814666170911144036.
   PubMedGoogle Scholar
• Konstantinos, L.; Maria, F.; Athina, G. Thiazoles and Thiazolidinones as COX/LOX Inhibitors. Molecules. 2018, 685, 23.
   Google Scholar
• Adileh, A.; Saeed, E.; Setareh, M.; Alireza, F. Thiazole in the Targeted Anticancer Drug Discovery. Future Med. Chem. 11, 15. DOI: 10.4155/fmc-2018-0416.
   Web of Science ®Google Scholar
• Romagnoli, R.; Baraldi, P. G.; Brancale, A.; Ricci, A.; Hamel, E.; Bortolozzi, R.; Basso, G.; Viola, G. Convergent Synthesis and Biological Evaluation of 2-amino4-(3′, 4′, 5′-Trimethoxyphenyl)-5-Aryl Thiazoles as Microtubule Targeting Agents. J. Med. Chem. 2011, 54, 5144–5153. DOI: 10.1021/jm200392p.
   PubMed Web of Science ®Google Scholar
• Romagnoli, R.; Baraldi, P. G.; Salvador, M. K.; Camacho, M. E.; Preti, D.; Aghazadeh Tabrizi, M.; Bassetto, M.; Brancale, A.; Hamel, E.; Bortolozzi, R.; et al. Synthesis and Biological Evaluation of 2-Substituted-4-(3′,4′,5′-trimethoxyphenyl)-5-aryl Thiazoles as Anticancer Agents. Bioorg. Med. Chem. 2012, 20, 7083–7094. DOI: 10.1016/j.bmc.2012.10.001.
   PubMed Web of Science ®Google Scholar
• Romagnoli, R.; Baraldi, P. G.; Salvador, K. M.; Preti, D.; Aghazadeh Tabrizi, M.; Brancale, A.; Fu, X.-H.; Li, J.; Zhang, S.-Z.; Hamel, E.; et al. Discovery and Optimization of a Series of 2-aryl-4-Amino-5-(3′,4′,5′-Trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents. J. Med. Chem. 2012, 55, 5433–5445. DOI: 10.1021/jm300388h.
   PubMed Web of Science ®Google Scholar
• Adileh, A.; Rezvan, E.; Setareh, M.; TayebehOghabi, B.; Zahra, E.-S.; Keivan, M.; Maliheh, S.; Saeed, E.; Alireza, F. Synthesis and Biological Evaluation of 4-Amino-5-Cinnamoylthiazoles as Chalcone-like Anticancer Agents. Eur. J. Med. Chem. 2018, 145, 404–412.
   PubMed Web of Science ®Google Scholar
• Majeed, R.; Sangwan, P. L.; Chinthakindi, P. K.; Khan, I.; Dangroo, N. A.; Thota, N.; Hamid, A.; Sharma, P. R.; Saxena, A. K.; Koul, S. Synthesis of 3-O-Propargylated Betulinic Acid and its 1,2,3-Triazoles as Potential Apoptotic Agents. Eur. J. Med. Chem. 2013, 63, 782–792. DOI: 10.1016/j.ejmech.2013.03.028.
   PubMed Web of Science ®Google Scholar
• Kankala, S.; Kankala, R. K.; Gundepaka, P.; Thota, N.; Nerella, S.; Gangula, M. R.; Guguloth, H.; Kagga, M.; Vadde, R.; Vasam, C. S. Regioselective Synthesis of Isoxazole-Mercaptobenzimidazole Hybrids and Their in Vivo Analgesic and anti-Inflammatory Activity Studies. Bioorg. Med. Chem. Lett. 2013, 23, 1306–1309. DOI: 10.1016/j.bmcl.2012.12.10.
   PubMed Web of Science ®Google Scholar
• Kotha, S.; Goyal, D.; Bitra, A.; Thota, N.; Kruger, H. G.; Anand, R. Diversity Oriented Approach toTriazole Based Peptidomimetics as Mammalian Sterile 20 Kinase Inhibitors. RSC Adv. 2013, 3, 24447–24454. DOI: 10.1039/c3ra44318c.
   Web of Science ®Google Scholar
• Kankala, S.; Thota, N.; Björkling, F.; Taylor, M. K.; Vadde, R.; Balusu, R. Silver Carbene Complexes: An Emerging Class of anticancer agents. Drug Dev. Res. 2019, 80, 188–199. DOI: 10.1002/ddr.21478.
   PubMed Web of Science ®Google Scholar
• Singh, P.; Amit, A.; Vipan, K. Recent Developments in Biological Activities of Chalcones: A Mini Review. Eur. J. Med. Chem. 2014, 85, 758–777. DOI: 10.1016/j.ejmech.2014.08.03.
   PubMed Web of Science ®Google Scholar